Caladrius Biosciences Inc (CLBS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Caladrius Biosciences Inc (CLBS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7476
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company that develops cell therapy products. The company offers multiple technology platforms targeting cardiovascular indications and autoimmune diseases. The company’s lead product CLBS03 is an autologous ex vivo polyclonal T regulatory cell clinical phase 2 therapy used in the treatment of type 1 diabetes mellitus. Its other product candidates include CLBS12 used in the treatment of critical limb ischemia; and CLBS14 used in the treatment of coronary microvascular dysfunction. The company offers T regulatory technology and CD34 technology. Caladrius serves biotechnology, pharmaceutical and medical product companies, and academic research institutions. The company operates in Basking Ridge, Irvine and New York, the US. Caladrius is headquartered in Basking Ridge, New Jersey, the US.

Caladrius Biosciences Inc (CLBS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Caladrius Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Caladrius Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Caladrius Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Caladrius Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Caladrius Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Caladrius Biosciences Inc, Medical Equipment, Deal Details 10
Partnerships 10
Caladrius Biosciences Enters into Research Agreement with University of Southern California and California Institute of Technology 10
NeoStem Enters into Co-Development Agreement with Invetech 11
Equity Offering 12
Caladrius Biosciences Plans to Raise up to USD25 Million in Public Offering of Shares 12
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 13
NeoStem Raises USD29 Million in Public Offering of Shares 14
NeoStem to Raise USD30 Million in Private Placement of Shares 15
NeoStem Completes Public Offering Of Shares For US$40.25 Million 16
NeoStem Files Registration Statement For Private Placement Of Shares For US$8 Million 17
NeoStem Completes Public Offering Of Shares For US$11.5 Million 18
NeoStem Completes Private Placement Of Common Stock For US$3 Million 19
NeoStem Completes Public Offering Of Units For US$6.8 Million 21
Asset Transactions 23
Hitachi Chemical Advanced Therapeutics Solutions Acquires Counter-Flow Centrifugation System from Caladrius Biosciences for USD2.5 Million 23
Acquisition 24
Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 24
NeoStem Acquires California Stem Cell 25
Caladrius Biosciences Inc – Key Competitors 27
Caladrius Biosciences Inc – Key Employees 28
Caladrius Biosciences Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 09, 2018: Caladrius Biosciences reports 2018 second quarter and first six months financial results 30
May 10, 2018: Caladrius Biosciences Reports 2018 First Quarter Financial Results 32
Mar 22, 2018: Caladrius Biosciences Reports 2017 Fourth Quarter and Year End Financial Results 33
Nov 09, 2017: Caladrius Biosciences Reports 2017 Third Quarter Results 35
Aug 10, 2017: Caladrius Biosciences Reports 2017 Second Quarter Results 37
May 15, 2017: Caladrius Biosciences Announces 2017 First Quarter Financial Results 39
Mar 17, 2017: Caladrius Biosciences Announces 2016 Fourth Quarter and Full Year Financial Results 41
Product News 43
Apr 09, 2018: Caladrius Biosciences to Participate at Upcoming April Conferences 43
May 01, 2017: Caladrius Biosciences to Participate at Upcoming May Conferences 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Caladrius Biosciences Inc, Medical Equipment, Key Facts, 2017 2
Caladrius Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Caladrius Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Caladrius Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Caladrius Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Caladrius Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Caladrius Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Caladrius Biosciences Enters into Research Agreement with University of Southern California and California Institute of Technology 10
NeoStem Enters into Co-Development Agreement with Invetech 11
Caladrius Biosciences Plans to Raise up to USD25 Million in Public Offering of Shares 12
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 13
NeoStem Raises USD29 Million in Public Offering of Shares 14
NeoStem to Raise USD30 Million in Private Placement of Shares 15
NeoStem Completes Public Offering Of Shares For US$40.25 Million 16
NeoStem Files Registration Statement For Private Placement Of Shares For US$8 Million 17
NeoStem Completes Public Offering Of Shares For US$11.5 Million 18
NeoStem Completes Private Placement Of Common Stock For US$3 Million 19
NeoStem Completes Public Offering Of Units For US$6.8 Million 21
Hitachi Chemical Advanced Therapeutics Solutions Acquires Counter-Flow Centrifugation System from Caladrius Biosciences for USD2.5 Million 23
Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 24
NeoStem Acquires California Stem Cell 25
Caladrius Biosciences Inc, Key Competitors 27
Caladrius Biosciences Inc, Key Employees 28
Caladrius Biosciences Inc, Other Locations 29
Caladrius Biosciences Inc, Subsidiaries 29

List of Figures
Caladrius Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Caladrius Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Caladrius Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Caladrius Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Caladrius Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Caladrius Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Caladrius Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Caladrius Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Caladrius Biosciences Inc (CLBS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fauji Fertilizer Co Ltd (FFC):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Co Ltd (FFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Sv. Sv. Konstantin I Elena Holding Ad
    Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report Summary Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Control4 Corporation (CTRL)-エネルギー分野:企業M&A・提携分析
    Summary Control4 Corporation (Control4) is a provider of automation systems and control solutions for homes and businesses. It focuses on smart lighting, networking solutions and safety and security solutions. The company offers personalized control solutions for lighting, video, music, energy and s …
  • Dance Biopharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • Berkem SA:企業の戦略・SWOT・財務情報
    Berkem SA - Strategy, SWOT and Corporate Finance Report Summary Berkem SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Comision Federal de Electricidad:企業の戦略的SWOT分析
    Comision Federal de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • GeneNews Ltd (GEN):企業の財務・戦略的SWOT分析
    Summary GeneNews Ltd (GeneNews) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNew …
  • AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析
    AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Taikisha Ltd
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Capture Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Capture Vascular Inc (Capture Vascular) is a medical device development company that develops and commercializes mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and …
  • Vectrus Inc (VEC):企業の財務・戦略的SWOT分析
    Vectrus Inc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NCsoft Corp (036570):企業の財務・戦略的SWOT分析
    NCsoft Corp (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Stellar Biotechnologies Inc (SBOT)-製薬・医療分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • XBiotech Inc (XBIT):製薬・医療:M&Aディール及び事業提携情報
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Dauntless Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dauntless Pharmaceuticals Inc (Dauntless Pharma) is a drug development company that develops therapeutic agents. The company’s pipeline products include DP1038 and DP2018. Its DP1038 is an intranasal octreotide formulation used as a therapeutic agent for the treatment of acromegaly and neuro …
  • Deutsche Bundesbank:企業の戦略的SWOT分析
    Deutsche Bundesbank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Torishima Pump Mfg Co Ltd (6363):企業の財務・戦略的SWOT分析
    Torishima Pump Mfg Co Ltd (6363) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hoya Corporation:企業のM&A・事業提携・投資動向
    Hoya Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hoya Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Torchmark Corp:企業の戦略・SWOT・財務情報
    Torchmark Corp - Strategy, SWOT and Corporate Finance Report Summary Torchmark Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆